Newsoara Hyk Biopharmaceutical (shanghai) Co., Ltd.

This study tests a new treatment for advanced small cell lung cancer that has stopped responding to standard therapies. The treatment combines an oncolytic virus (Olvi-Vec) with standard chemotherapy drugs. The goal is to see if this combination is safe and can shrink tumors in 2…